Toremifene for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia: Results of a Double-Blind, Placebo Controlled, Phase IIB Clinical Trial-Reference-Cited by-同舟云学术

Toremifene for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia: Results of a Double-Blind, Placebo Controlled, Phase IIB Clinical Trial

Published:2006-09 Issue:3 Volume:176 Page:965-971
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Price David¹,Stein Barry²,Sieber Paul³,Tutrone Ronald⁴,Bailen James⁵,Goluboff Erik⁶,Burzon Daniel⁷,Bostwick David⁸,Steiner Mitchell⁹,

Affiliation:

1. Regional Urology L. L. C., Shreveport, Louisiana

2. University Urological Associates, Inc., Providence, Rhode Island

3. Urology Associates of Lancaster, Lancaster, Pennsylvania

4. Chesapeake Urology Associates, Baltimore, Maryland

5. Metropolitan Urology, P. S. C., Jeffersonville, Indiana

6. Department of Urology, Columbia University, New York, New York

7. Coastal Urology Associates, Brick, New Jersey

8. Bostwick Laboratories, Richmond, Virginia

9. GTx, Inc., Memphis, Tennessee

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. Evolution of isolated high-grade prostate intraepithelial neoplasia in a Mediterranean patient population;Algaba;Eur Urol,1999

2. Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance;Balaji;J Urol,1999

3. High-grade prostatic intraepithelial neoplasia;Bostwick;Cancer,1995

4. Molecular biology of prostatic intraepithelial neoplasia;Bostwick;Prostate,1996

5. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia;Bostwick;Cancer,1996

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen receptor and estrogen receptor variants in prostate and breast cancers;The Journal of Steroid Biochemistry and Molecular Biology;2024-07

2. The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression;Journal of Clinical Investigation;2024-04-16

3. The Transcriptomic Profiles of ESR1 and MMP3 Stratify the Risk of Biochemical Recurrence in Primary Prostate Cancer beyond Clinical Features;International Journal of Molecular Sciences;2023-05-07

4. The adverse effect of anticancer drug toremifene on vascular smooth muscle cells is an important aspect of its tumor growth inhibition;Journal of Cancer Research and Clinical Oncology;2023-04-10

5. To block or not to block—hormonal signaling in the treatment of cancers;Frontiers in Endocrinology;2023-02-20